#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hypomagnesaemia Heavy menstrual bleeding Non-Hodgkin's lymphoma unspecified histology indolent Rhabdomyosarcoma recurrent ABO haemolytic disease of newborn Pyoderma gangrenosum Acute graft versus host disease in intestine Vascular calcification Waldenstrom's macroglobulinaemia Small intestine adenocarcinoma Pemphigoid Multifocal motor neuropathy Soft tissue sarcoma Drug eruption Prodromal Alzheimer's disease More trials…

    Learn about Rare Diseases

    Castleman’s disease – Life with Disease Antisynthetase syndrome – Life with Disease Vascular malformation – Treatment Hairy cell leukaemia – Diagnostics Myelodysplastic syndrome – Basic Information Nephroblastoma Gaucher’s disease type III – Life with Disease Sarcoidosis Combined immunodeficiency – Life with Disease Glomerulonephritis membranoproliferative More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Spironolactone Propranolol Calcium Folinate Mps-112 Cipepofol HYDROGEN Amikacin Sulfate MOLNUPIRAVIR Mesalazine Capsaicin Lenalidomide Bempedoic Acid VHB937 Resatorvid Eptinezumab Ribitol Isosorbide Dinitrate Kbp-336 Darovasertib Favezelimab More therapies…

    Learn about Your Condition

    Systemic candida Diffuse large B-cell lymphoma Lung transplant rejection Small for dates baby Myotonia Migraine Diabetic foot infection Vulvovaginal discomfort Breast cancer metastatic Supraventricular tachycardia Chondrosarcoma Colonoscopy Osteomyelitis acute Gastric cancer stage IV Large cell lung cancer stage 0 More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Szpital Uniwersytecki Nr 1 Im. Dr. A. Jurasza W Bydgoszczy…

Szpital Uniwersytecki Nr 1 Im. Dr. A. Jurasza W Bydgoszczy

Ul. Marii Curie Sklodowskiej 9, Bydgoszcz, 85-094, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Long-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Hidradenitis
    Investigated Drugs:
    • Remibrutinib
    Belgium Bulgaria Czechia France Germany Greece +6

  • Study of Olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)

    Not yet recruiting

    3 1
    Austria Belgium Bulgaria Czechia Denmark France +11

  • Study on the Effectiveness and Safety of Stem Cell Therapy for Urinary Incontinence in Patients After Prostate Surgery

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Urinary incontinence
    Investigated Drugs:
    • Autologous Adipose-Derived Mesenchymal Stem Cells In Vitro Expanded
    • Sodium Chloride
    Poland

  • Study on Treating Acute Myeloid Leukemia in Children and Adolescents Using CPX-351, Gemtuzumab Ozogamicin, and a Drug Combination

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Anhydrous Cyclophosphamide
    • Idarubicin Hydrochloride
    • Mitoxantrone Hydrochloride
    Austria Czechia Germany Greece Italy Poland

  • Study of Cytarabine and Daunorubicin for Treating Myeloid Leukemia in Children with Down Syndrome

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Trisomy 21
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Cytarabine
    • Daunorubicin
    Austria Belgium Czechia Germany Italy The Netherlands +1

  • Study on the Effects of Remibrutinib for Adults with Moderate to Severe Hidradenitis Suppurativa

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hidradenitis
    Investigated Drugs:
    • SALICYLIC ACID
    • Clindamycin Hydrochloride
    • Triamcinolone Acetonide
    Bulgaria Denmark Germany Greece Italy Poland +3

  • Study of Levosimendan and Glucose Monohydrate for Patients with Low Ejection Fraction Takotsubo Syndrome

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Stress cardiomyopathy
    Investigated Drugs:
    • Levosimendan
    • Glucose Monohydrate
    Poland

  • Study on How Sacubitril/Valsartan and Enalapril Affect Lung Pressure in Patients with Heart Failure with Reduced Ejection Fraction

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Heart failure with reduced ejection fraction
    Investigated Drugs:
    • Enalapril Maleate
    • Sacubitril
    • Valsartan
    Poland

  • Study on the Effects of Sertraline on Anxiety and Depression in Heart Failure Patients with Preserved Ejection Fraction

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Anxiety
    • Heart failure with preserved ejection fraction
    • Depression
    Investigated Drugs:
    • Sertraline
    Poland

  • Study on Dabigatran and Ticagrelor for Patients with Acute Coronary Syndrome and Atrial Fibrillation Undergoing Heart Procedure

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute coronary syndrome
    Investigated Drugs:
    • Ticagrelor
    Poland
Previous Page
1 2 3 4
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!